Wegovy (semaglutide) 2.4 mg
Price range: £ 139 through £ 287
Description
what is Wegovy (semaglutide) 2.4 mg
Wegovy (semaglutide) is a prescription medication, available as a once-weekly injection or a once-daily pill, approved for chronic weight management and to reduce the risk of serious cardiovascular events in eligible adults and adolescents . It must be used in conjunction with a reduced-calorie diet and increased physical activity.
Key Information
Active Ingredient: Wegovy’s active ingredient is semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics a natural hormone that regulates appetite, helping you feel fuller sooner and reducing hunger and cravings.
- Indications: It is prescribed for:
- Adults with obesity (BMI of 30 kg/m² or greater) or overweight (BMI of at least 27 kg/m² but less than 30 kg/m²) who have at least one weight-related medical condition, such as high blood pressure, high cholesterol, or diabetes.
- Adolescents aged 12 years and older with obesity (BMI at or above the 95th percentile for their age and gender).
- Reducing the risk of cardiovascular death, heart attack, and stroke in adults with established cardiovascular disease who also have obesity or are overweight.
- Administration:
- Injection: A self-administered subcutaneous injection is taken once weekly in the abdomen, thigh, or upper arm. Doses are gradually increased over 16 weeks to reduce gastrointestinal side effects.
- Pill: A once-daily tablet recently approved and launched in the US market. The pill should be swallowed whole and not split or chewed.
- Effectiveness: Clinical trials show that participants using Wegovy along with diet and exercise can achieve significant weight loss, with average reductions of around 15% of body weight over 68 weeks in one study.
- Common Side Effects: The most common side effects are gastrointestinal in nature, including nausea, diarrhea, vomiting, constipation, stomach pain, and headache.
- Serious Side Effects: Wegovy may cause serious side effects, including pancreatitis, gallbladder problems, severe stomach problems, and an increased risk of low blood sugar (hypoglycemia) in patients with diabetes.
Wegovy requires a prescription from a healthcare professional who can determine eligibility and monitor progress and potential side effects. It may need to be continued long-term to maintain weight loss.
Additional information
| Dosage | 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg |
|---|
2 reviews for Wegovy (semaglutide) 2.4 mg
Add a review
Related products
-
- wegovy
Wegovy (semaglutide)
- Price range: £ 139 through £ 287
- Select options This product has multiple variants. The options may be chosen on the product page
-
- wegovy
Wegovy (semaglutide) 0.25 mg
- Price range: £ 139 through £ 287
- Select options This product has multiple variants. The options may be chosen on the product page
-
- wegovy
Wegovy (semaglutide) 1.7 mg
- Price range: £ 139 through £ 287
- Select options This product has multiple variants. The options may be chosen on the product page
Rapheal Kline –
Fast shipping and professional service. Since starting Wegovy 2.4mg, I’ve lost noticeable weight and feel more confident and active.
Imani T –
Everything arrived securely and on schedule. The results have been steady, and I feel fitter overall without feeling overwhelmed.